Saving Lives at Birth: novel microarray patch to treat neonatal sepsis receives international funding

Mary-Carmel Kearney; Helen Quinn

Saving Lives at Birth: novel microarray patch to treat neonatal sepsis receives international funding

School of Pharmacy

Research output: Contribution to specialist publication › Article

Abstract

Researchers at Queen’s University Belfast have developed a novel microarray patch to deliver antibiotics for the treatment of neonatal sepsis, a significant cause of childhood mortality that accounts for 26-36% of neonatal deaths globally. The potential of this microarray patch to offer an affordable, less-invasive and user-friendly treatment option was recently recognised by Saving Lives at Birth, a scheme which aims to identify and fund novel, scalable and sustainable solutions to improve infant and maternal health.

Original language	English
Volume	13
No.	2
Specialist publication	Infant Journal
Publication status	Published - 01 Mar 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://www.infantjournal.co.uk/pdf/inf_074_rth.pdfLicence: Unspecified

Cite this

@misc{c87cdc1e38114529a3aeab204346fe7a,

title = "Saving Lives at Birth: novel microarray patch to treat neonatal sepsis receives international funding",

abstract = "Researchers at Queen{\textquoteright}s University Belfast have developed a novel microarray patch to deliver antibiotics for the treatment of neonatal sepsis, a significant cause of childhood mortality that accounts for 26-36% of neonatal deaths globally. The potential of this microarray patch to offer an affordable, less-invasive and user-friendly treatment option was recently recognised by Saving Lives at Birth, a scheme which aims to identify and fund novel, scalable and sustainable solutions to improve infant and maternal health.",

author = "Mary-Carmel Kearney and Helen Quinn",

year = "2017",

month = mar,

day = "1",

language = "English",

volume = "13",

journal = "Infant Journal",

}

TY - GEN

T1 - Saving Lives at Birth: novel microarray patch to treat neonatal sepsis receives international funding

AU - Kearney, Mary-Carmel

AU - Quinn, Helen

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Researchers at Queen’s University Belfast have developed a novel microarray patch to deliver antibiotics for the treatment of neonatal sepsis, a significant cause of childhood mortality that accounts for 26-36% of neonatal deaths globally. The potential of this microarray patch to offer an affordable, less-invasive and user-friendly treatment option was recently recognised by Saving Lives at Birth, a scheme which aims to identify and fund novel, scalable and sustainable solutions to improve infant and maternal health.

AB - Researchers at Queen’s University Belfast have developed a novel microarray patch to deliver antibiotics for the treatment of neonatal sepsis, a significant cause of childhood mortality that accounts for 26-36% of neonatal deaths globally. The potential of this microarray patch to offer an affordable, less-invasive and user-friendly treatment option was recently recognised by Saving Lives at Birth, a scheme which aims to identify and fund novel, scalable and sustainable solutions to improve infant and maternal health.

M3 - Article

VL - 13

JO - Infant Journal

JF - Infant Journal

ER -

Saving Lives at Birth: novel microarray patch to treat neonatal sepsis receives international funding

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this